The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Study of anlotinib combined with icotinib as the first-line treatment in non-small cell lung cancer (NSCLC) patients harboring activating EGFR mutations (ALTER-L004).
 
Dingzhi Huang
No Relationships to Disclose
 
Diansheng Zhong
No Relationships to Disclose
 
Cuiying Zhang
No Relationships to Disclose
 
Yan Zhang
No Relationships to Disclose
 
Yanhong Shang
No Relationships to Disclose
 
Liuchun Wang
No Relationships to Disclose